{"nct_id":"NCT02392559","title":"Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders","status":"COMPLETED","status_verified_date":"2022-11","start_date":"2016-03-24","start_date_type":"ACTUAL","primary_completion_date":"2019-11-25","primary_completion_date_type":"ACTUAL","completion_date":"2019-11-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}